Valencia, Spain

Vicente Felipo Orts

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vicente Felipo Orts: Innovator in Neuroprotective Compounds

Introduction

Vicente Felipo Orts is a notable inventor based in Valencia, Spain. He has made significant contributions to the field of neuroprotective compounds, particularly through his innovative patent that addresses various neurodegenerative disorders. His work is crucial in the ongoing search for effective treatments for conditions that affect the nervous system.

Latest Patents

Vicente Felipo Orts holds a patent for "N-alkylglycine trimeres capable of protecting neurons against excitotoxic aggressions and compositions containing such trimeres." This patent includes a detailed description of N-alkylglycine trimeres, their stereoisomers, racemic mixtures, and salts. The compounds are designed to block L-glutamate receptors, making them potentially useful in treating disorders such as cerebral ischemia, migraine, depression, Huntington's disease, Parkinson's disease, Alzheimer's disease, senile dementia, epilepsy, and amyotrophic lateral sclerosis.

Career Highlights

Vicente is associated with Diverdrugs, S.L., where he continues to develop and refine his innovative ideas. His work has garnered attention for its potential impact on treating debilitating neurological conditions. The focus on neuroprotection highlights his commitment to advancing medical science and improving patient outcomes.

Collaborations

Vicente has collaborated with notable colleagues, including Carmen Montoliu Felix and Antonio Ferrer Montiel. These partnerships have likely contributed to the depth and breadth of his research and development efforts.

Conclusion

Vicente Felipo Orts stands out as an inventor dedicated to creating solutions for neurodegenerative disorders. His innovative patent reflects a significant advancement in the field of neuroprotection, showcasing his commitment to improving health outcomes for individuals affected by these challenging conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…